These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1722012)

  • 1. Cellular ageing of Alzheimer's disease and Down syndrome cells in culture.
    Carmeliet G; David G; Cassiman JJ
    Mutat Res; 1991; 256(2-6):221-31. PubMed ID: 1722012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome.
    Ledoux S; Bergeron C; Nalbantoglu J; Gauthier S; Cashman NR
    Neurosci Lett; 1995 Jun; 193(2):137-9. PubMed ID: 7478160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
    Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
    Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata.
    Coulson EJ; Barrett GL; Storey E; Bartlett PF; Beyreuther K; Masters CL
    Brain Res; 1997 Oct; 770(1-2):72-80. PubMed ID: 9372205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.
    Ghiso J; Rostagno A; Gardella JE; Liem L; Gorevic PD; Frangione B
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1053-9. PubMed ID: 1281980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
    Golaz J; Charnay Y; Vallet P; Bouras C
    Encephale; 1991; 17(1):29-31. PubMed ID: 1669030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration.
    de la Monte SM
    J Neural Transm Suppl; 1999; 57():1-19. PubMed ID: 10666665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth properties of familial Alzheimer skin fibroblasts during in vitro aging.
    Tesco G; Vergelli M; Amaducci L; Sorbi S
    Exp Gerontol; 1993; 28(1):51-8. PubMed ID: 8436204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology.
    Hyman BT
    Ann Neurol; 1996 Aug; 40(2):135-6. PubMed ID: 8773592
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dinucleotide deletions in neuronal transcripts: a novel type of mutation in non-familial Alzheimer's disease and Down syndrome patients.
    Hol EM; Neubauer A; de Kleijn DP; Sluijs JA; Ramdjielal RD; Sonnemans MA; van Leeuwen FW
    Prog Brain Res; 1998; 117():379-95. PubMed ID: 9932421
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth properties and in vitro life span of Alzheimer disease and Down syndrome fibroblasts. A blind study.
    Carmeliet G; Hauman R; Dom R; David G; Fryns JP; Van den Berghe H; Cassiman JJ
    Mech Ageing Dev; 1990 Mar; 53(1):17-33. PubMed ID: 2139155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
    Hendriks L; Van Broeckhoven C
    Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.